A cursory search reveals two very interesting journal articles.
The Ketogenic Diet Is an Effective Adjuvant to Radiation Therapy for the Treatment of Malignant Glioma (full text available)
Mohammed G. Abdelwahab et al.
May 2012
Ketogenic Diets Enhance Oxidative Stress and Radio-Chemo-Therapy Responses in Lung Cancer Xenografts
Bryan G. Allen et al.
July 2013
These are are both mouse studies which used the commercially available shake "KetoCal" to implement the ketogenic diet. KetoCal is used to implement a ketogenic diet in kids with epilepsy. Abdelwahab et al. studied mice given brain cancer, while Allen et al. looked at mice implanted with lung cancer in their torso (ie. not in the lungs themselves).
In most of these experiments you'll see four groups.
- Controls: Mice fed the standard lab chow diet and given no cancer treatments.
- Ketogenic Only: Mice put on a ketogenic diet and given no cancer treatments.
- Radiation/Chemo Only: Mice on the standard diet given cancer treatments.
- Ketogenic with Radiation/Chemo: Mice on the ketogenic diet given cancer treatments.
The question is which group would you like to be in if you had a choice.
Grains of Salt
The Abdelwahab study was funded by the company that makes KetoCal. They state: "The funders had no role in data collection and analysis, decision to
publish or preparation of the manuscript, but did input to the study
design." The Allen study was funded by an NIH grant.
These are studies of rodents implanted with cancerous cells, so the results are not guaranteed to be replicated in humans who've developed cancer endogenously. I've read that successes in rodent cancer research have not always translated into similar successes in human treatments, to the frustration of the cancer research community. It is easy to keep in mind that the efficacy of the treatments in the studies when applied to humans may or may not mirror those seen in the rodents.
Aside
It would be wrong to take the fact that these are rodent studies as a license to simply write them off without consideration. The reason thousands of studies are done each year on rodents is not because humans are fascinated with rodents, or because rodents are convenient subjects, it is because the results are relevant to human biology.
Hodgkin and Huxley received a Nobel Prize for their work in the 1950's
elucidating the electrical workings of neurons. The neurons they studied
happened to be those of the giant squid, because squid neurons were big enough to
manipulate and measure using the tools available. If there were Hodgkin and Huxley haters at that time, they probably would have dismissed the research by arguing that insights about giant squid
neurons were irrelevant to human biology.
The most powerful aspect of rodent studies is that they can be setup as true experiments, in which the rodents are randomly assigned to experimental groups, the manipulation is conducted, and results measured. The results which come from such experiments are highly informative and allow the researcher to conclude that "treatment X caused result Y."
In epidemiological research, on the other hand, there is no random assignment to groups, and therefore no statements as to cause can be made based on the results. The epidemiological researcher can only say that "in this analysis, people who ate more vegetables had less heart attacks." They can't say that eating vegetables causes less heart attacks, because it could be that vegetables actually cause heart attacks but people who eat vegetables also tend not to smoke.
So, if there is a good reason to think that a particular result in rodents would not apply in humans, that's one thing. But to dismiss a result in rodents simply because it is not a human study is a bad habit. On the other hand, if someone wants to shrug off the results of an epidemiological study without a logical reason then I can't really blame them.
Further, the results discussed below are not random. The effects of no treatment vs chemotherapy and radiation are as one would predict based on the fact that chemotherapy and radiation are the current standard of care for cancer. So there is no a priori reason to think that the effect of adding a ketogenic diet to chemo/radiation therapy in humans would be radically different from the effect seen in rodents below.
Enough of that. What did these studies find?
Tumor Growth
In these tumor growth graphs, you want to be in the line with lowest slope, representing the group whose tumors grew the slowest. Allen et al. looked at several different types of radiation treatment, resulting in the multiple graphs below.
I don't know if it is really necessary but in order to avoid any possible copyright issues for the Allen paper, which is not freely available, I've created new graphs from scratch in Excel by eyeballing the originals. It allows me to change the emphasis anyway. The treatments involving ketosis are displayed in dotted lines.
Based on these results it looks like ketosis alone is of little or no help in inhibiting tumor growth, but adding ketosis to chemo and/or radiation results in the least tumor growth obtained, sometimes by a wide margin.
Adbelwahab et al. did not report changes in tumor weight.
Survival
Regardless of changes in tumor weight, we want to know which group of mice lived the longest. The survival graphs are more difficult to replicate so I'll just describe Allen et al.'s results.
Allen et al. Experiment 1
Controls: last survivors died on day 45
Radiation: last survivors died on day 50
Keto-Radiation: last survivors died on day 80
Keto-Chemo-Radiation: 20% still alive on day 80
Allen et al. Experiment 2
Controls: last survivors died around day 38
Keto: last survivors died on day 40
Radiation: Roughly 22% still alive at day 80
Keto-Radiation: 100% still alive at day 80*
Allen et al. Experiment 3
Controls: last survivors died on day 41
Keto: last survivors died on day 35
Radiation: last survivors died on around day 48
Keto-Radiation: 100% survived past day 50, but then only 20% made it past day 60*
* Important to note that the mice in experiment three were on the ketogenic diet for seven days total, whereas the mice in experiment two were on the ketogenic diet for 81 days at which point the experiment was terminated. The two experiments had different radiation regimens as well.
Abdelwahab et al. have their survival graphs split into two pieces, which I have helpfully smushed together into a single graph below. The x-axis is day number, the y-axis is percentage of mice still alive.
In the Abdelwahab et al. study, roughly 80% of the mice in the keto-radiation group survived indefinitely. Did they still have tumors? Here's how the authors describe the results.
"Nine out of the 11 animals treated with [KetoCal] in combination with radiation were apparently cured of their implanted tumor...In the animal[s] treated with radiation and [KetoCal] the presence of growing
tumor can be seen for the first [few] weeks following implantation,
reaching a maximum bioluminescent [around] day 9 following tumor implantation. This was followed by a near
exponential decline that approaches background levels 60 days following
implantation. Bioluminescence remained undetectable and on day 104
post-implantation the 9 surviving animals treated with radiation and [KetoCal] were switched from KC to the standard rodent chow. There was no
detectable recurrence of tumor as demonstrated by the continued absence
of detectable bioluminescent signal. The animals were sacrificed on day
299. Histological evidence ... from the apparently cured [KetoCal] plus
radiation animals showed no evidence of tumor cells in or near the area
of implantation."
In summary, the group that lived the longest in all four experiments was the one that combined radiation and/or chemo with a ketogenic diet.
Body Weight Maintenance
There is concern that since the ketogenic diet is a restricted diet it will lead to weight loss. In Allen et al. experiment 1, the authors report:
"comparisons of animal weights show that all treatments were well tolerated as shown by a lack of significant weight change"
In fact, the ketogenic mice are the heaviest group in 13 out of the 17 days displayed in Allen et al.'s graph.
Abdelwahab et al. divided their figure into two pieces again, so I have again helpfully mangled the two pieces into a single figure in which they appear on the same horizontal time scale.
There was essentially no difference in bodyweight between the controls fed the standard mice chow and the mice fed KetoCal. However, the KetoCal fed mice who were given radiation therapy retained their weight much better than those fed the standard diet. Perhaps that is to be expected given that their tumors disappeared and most of them survived.
In summary, it appears that the ketogenic diet had a neutral to positive effect on the bodyweights of the mice in these studies.
Will These Results be Replicated in Human Studies?
No one knows yet. Only a few small and flawed trials have been conducted in humans. However, clinical trials are now starting up, as
previously discussed (
KETOLUNG and
KETOPAN). The fact that these clinical trials are in the works is very significant. It means that:
- Enough evidence has been published already to provide a scientific justification for conducting clinical trials, which are not trivial undertakings.
- The evidence is strong enough to convince not just a few curious oncologists, but entire panels of conservative experts at agencies such as the NIH that fund such trials, as well as the institutional review boards that approve trial protocols for human safety.
- These trials are proceeding despite the fact that there is no drug company to push them along in hopes of discovering the next blockbuster drug (KetoCal is not required for ketosis, see below).
In other words, the idea of using a ketogenic diet to help fight cancer is not some kooky idea from the natural health fringe. It may not yet be mainstream oncology, but it is backed by reasonably compelling scientific findings.
Translating drug therapies from rodents to humans is difficult and incredibly risky. In contrast, the ketogenic diet is an established medical therapy as well as something that many people already do by choice. Allen et al. included the following sidebar titled "Translational Relevance" in their article.
"Ketogenic diets are high in fat, low in carbohydrates, and are well established as an alternative therapy for childhood epilepsy. This report shows that a ketogenic diet enhances radio-chemo-therapy responses as well as enhancing oxidative stress in human lung cancer xenografts. As ketogenic diets are an established therapy in humans, these studies may be rapidly translated into the clinical setting, potentially allowing for improved cancer control without added normal tissue toxicity."
It is lucky that a therapy offering potential benefits such as those above doesn't have to undergo many years of testing for safety before it can be offered as an option for patients.
Final Notes
Although I referred to the mice in the above studies as being on the "ketogenic diet," I should have said "the mice given the KetoCal diet." It is possible that it wasn't the ketosis that helped those mice but some component of the KetoCal shake. However, that doesn't seem all that likely. In fact, it is kind of amazing that mice with cancer could recover on a KetoCal only diet, since KetoCal is just an industrial food-like substance consisting primarily of
cancer-promoting soybean oil and fortified with vitamins and minerals. It's basically a ketogenic version of Ensure. Such foods are usually associated with poor outcomes no matter how hard they try to imitate the components of real food.
So we can assume for now that it was the ketogenic-ness of the diet that produced the anti-cancer effect seen in these studies. It is encouraging to consider that these researchers might have gotten even better results with a ketogenic mouse diet consisting of healthier foods.
That's all I have on these two articles for now.